Survey of the Opinions, Knowledge and Practices of Surgeons and Internists Regarding Helicobacter pylori Test-and-Treat Policy
BACKGROUNDHelicobacter pylori infection is highly prevalent and may cause disease in 10% to 15% of infected individualsduodenal and gastric ulcer, gastric cancer and gastric lymphoma. Guidelines for a test-and-treat policy have been published by the European H. pylori working group in Maastricht. GO...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical gastroenterology 2003-02, Vol.36 (2), p.139-143 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 143 |
|---|---|
| container_issue | 2 |
| container_start_page | 139 |
| container_title | Journal of clinical gastroenterology |
| container_volume | 36 |
| creator | Niv, Yaron Abuksis, Galia |
| description | BACKGROUNDHelicobacter pylori infection is highly prevalent and may cause disease in 10% to 15% of infected individualsduodenal and gastric ulcer, gastric cancer and gastric lymphoma. Guidelines for a test-and-treat policy have been published by the European H. pylori working group in Maastricht.
GOALSTo assess the current approach to H. pylori–related diseases, indications for testing and eradication therapy, among internists and surgeons of a University affiliated medical center.
STUDYA 15-items questionnaire was formulated according to the Maastricht II test-and-treat recommendation and distributed among the physicians of 6 internal medicine departments and the department of surgery. The questionnaires were completed anonymously at the department's staff meeting, under the supervision of the head of the department. All questions required a yes/no answer; the maximum possible score was 15. The relative ratio (RR) of correct answers was calculated for every question and by subgroups as followsall participants, internists, surgeons, experts and residents in internal medicine and surgery.
RESULTSThe response rate was 68% (55 out of 80 physicians). Total score for all participants was 10.9 (RR = 0.73), significantly lower than the maximum score of 15 (RR = 1.00). The internists had significantly higher average score than the surgeons for 2 questionscausative agent in gastric cancer (p = 0.003) or gastric lymphoma (p = 0.003), 1 question about triple therapy, PPI, penicillin and azythromycin being not recommended (p = 0.022), and for 1 question of test-and-treat policyshould this strategy apply to family members of gastric cancer patients (p = 0.045). Only 56% of the internists and 21% of surgeons knew what MALToma is, and the correlation with H. pylori infection.
CONCLUSIONKnowledge of Surgeons and Internists regarding H. pylori infection and correlation with diseases or test and treat policy should be improved. |
| doi_str_mv | 10.1097/00004836-200302000-00010 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72987108</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72987108</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3860-b686ce726393cebd9e4992eff891636807c914995730cedfaa43d001849ac2413</originalsourceid><addsrcrecordid>eNp1kU9vFCEYh4mxsWv1KxgueupYGNgBjqaxtrFJG13PhGXe2UVZWGHGzV787L7trvYkCZC8PD_-PBBCOXvPmVEXDJvUomtaxgTDgTXYOXtGZnwuDJYFf05mjJu2YcqwU_Ky1u9IKCH4C3LK27mU3KgZ-f11Kr9gT_NAxzXQu21IIad6Tj-nvIvQr4C61NP74vwYPNQHECMrQOhx5SaNUFKoY6VfYOVKH9KKXkMMPi8xA4Vu9zGXQBdQxwYTzaKAG-l9RmT_ipwMLlZ4fZzPyLerj4vL6-b27tPN5YfbxgvdsWbZ6c6DajthhIdlb0Aa08IwaMM70WmmvOFYmivBPPSDc1L0-FwtjfOt5OKMvDvsuy3554Q3sZtQPcToEuSpWtUarTjTCOoD6EuutcBgtyVsXNlbzuyDe_vXvf3n3j66x-ib4xnTcgP9U_AoG4G3R8BV7-JQXPKhPnFy3mopOuTkgdvliALrjzjtoNg1uDiu7f_-XvwBckOb_A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72987108</pqid></control><display><type>article</type><title>Survey of the Opinions, Knowledge and Practices of Surgeons and Internists Regarding Helicobacter pylori Test-and-Treat Policy</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Niv, Yaron ; Abuksis, Galia</creator><creatorcontrib>Niv, Yaron ; Abuksis, Galia</creatorcontrib><description>BACKGROUNDHelicobacter pylori infection is highly prevalent and may cause disease in 10% to 15% of infected individualsduodenal and gastric ulcer, gastric cancer and gastric lymphoma. Guidelines for a test-and-treat policy have been published by the European H. pylori working group in Maastricht.
GOALSTo assess the current approach to H. pylori–related diseases, indications for testing and eradication therapy, among internists and surgeons of a University affiliated medical center.
STUDYA 15-items questionnaire was formulated according to the Maastricht II test-and-treat recommendation and distributed among the physicians of 6 internal medicine departments and the department of surgery. The questionnaires were completed anonymously at the department's staff meeting, under the supervision of the head of the department. All questions required a yes/no answer; the maximum possible score was 15. The relative ratio (RR) of correct answers was calculated for every question and by subgroups as followsall participants, internists, surgeons, experts and residents in internal medicine and surgery.
RESULTSThe response rate was 68% (55 out of 80 physicians). Total score for all participants was 10.9 (RR = 0.73), significantly lower than the maximum score of 15 (RR = 1.00). The internists had significantly higher average score than the surgeons for 2 questionscausative agent in gastric cancer (p = 0.003) or gastric lymphoma (p = 0.003), 1 question about triple therapy, PPI, penicillin and azythromycin being not recommended (p = 0.022), and for 1 question of test-and-treat policyshould this strategy apply to family members of gastric cancer patients (p = 0.045). Only 56% of the internists and 21% of surgeons knew what MALToma is, and the correlation with H. pylori infection.
CONCLUSIONKnowledge of Surgeons and Internists regarding H. pylori infection and correlation with diseases or test and treat policy should be improved.</description><identifier>ISSN: 0192-0790</identifier><identifier>EISSN: 1539-2031</identifier><identifier>DOI: 10.1097/00004836-200302000-00010</identifier><identifier>PMID: 12544197</identifier><identifier>CODEN: JCGADC</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins, Inc</publisher><subject>Academic Medical Centers - standards ; Anti-Bacterial Agents - therapeutic use ; Azithromycin - therapeutic use ; Bacterial diseases ; Bacterial diseases of the digestive system and abdomen ; Biological and medical sciences ; Data Collection ; Drug Therapy, Combination ; Gastritis - complications ; Gastritis - diagnosis ; Gastritis - therapy ; General Surgery - statistics & numerical data ; Guideline Adherence - statistics & numerical data ; Health Knowledge, Attitudes, Practice ; Helicobacter Infections - complications ; Helicobacter Infections - diagnosis ; Helicobacter Infections - therapy ; Helicobacter pylori ; Human bacterial diseases ; Humans ; Infectious diseases ; Internship and Residency - statistics & numerical data ; Israel ; Lymphoma, B-Cell, Marginal Zone - diagnosis ; Lymphoma, B-Cell, Marginal Zone - therapy ; Medical sciences ; Penicillins - therapeutic use ; Peptic Ulcer - complications ; Peptic Ulcer - diagnosis ; Peptic Ulcer - therapy ; Practice Guidelines as Topic ; Referral and Consultation - statistics & numerical data ; Stomach Neoplasms - diagnosis ; Stomach Neoplasms - therapy ; Tropical medicine</subject><ispartof>Journal of clinical gastroenterology, 2003-02, Vol.36 (2), p.139-143</ispartof><rights>2003 Lippincott Williams & Wilkins, Inc.</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3860-b686ce726393cebd9e4992eff891636807c914995730cedfaa43d001849ac2413</citedby><cites>FETCH-LOGICAL-c3860-b686ce726393cebd9e4992eff891636807c914995730cedfaa43d001849ac2413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14528436$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12544197$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Niv, Yaron</creatorcontrib><creatorcontrib>Abuksis, Galia</creatorcontrib><title>Survey of the Opinions, Knowledge and Practices of Surgeons and Internists Regarding Helicobacter pylori Test-and-Treat Policy</title><title>Journal of clinical gastroenterology</title><addtitle>J Clin Gastroenterol</addtitle><description>BACKGROUNDHelicobacter pylori infection is highly prevalent and may cause disease in 10% to 15% of infected individualsduodenal and gastric ulcer, gastric cancer and gastric lymphoma. Guidelines for a test-and-treat policy have been published by the European H. pylori working group in Maastricht.
GOALSTo assess the current approach to H. pylori–related diseases, indications for testing and eradication therapy, among internists and surgeons of a University affiliated medical center.
STUDYA 15-items questionnaire was formulated according to the Maastricht II test-and-treat recommendation and distributed among the physicians of 6 internal medicine departments and the department of surgery. The questionnaires were completed anonymously at the department's staff meeting, under the supervision of the head of the department. All questions required a yes/no answer; the maximum possible score was 15. The relative ratio (RR) of correct answers was calculated for every question and by subgroups as followsall participants, internists, surgeons, experts and residents in internal medicine and surgery.
RESULTSThe response rate was 68% (55 out of 80 physicians). Total score for all participants was 10.9 (RR = 0.73), significantly lower than the maximum score of 15 (RR = 1.00). The internists had significantly higher average score than the surgeons for 2 questionscausative agent in gastric cancer (p = 0.003) or gastric lymphoma (p = 0.003), 1 question about triple therapy, PPI, penicillin and azythromycin being not recommended (p = 0.022), and for 1 question of test-and-treat policyshould this strategy apply to family members of gastric cancer patients (p = 0.045). Only 56% of the internists and 21% of surgeons knew what MALToma is, and the correlation with H. pylori infection.
CONCLUSIONKnowledge of Surgeons and Internists regarding H. pylori infection and correlation with diseases or test and treat policy should be improved.</description><subject>Academic Medical Centers - standards</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Azithromycin - therapeutic use</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the digestive system and abdomen</subject><subject>Biological and medical sciences</subject><subject>Data Collection</subject><subject>Drug Therapy, Combination</subject><subject>Gastritis - complications</subject><subject>Gastritis - diagnosis</subject><subject>Gastritis - therapy</subject><subject>General Surgery - statistics & numerical data</subject><subject>Guideline Adherence - statistics & numerical data</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Helicobacter Infections - complications</subject><subject>Helicobacter Infections - diagnosis</subject><subject>Helicobacter Infections - therapy</subject><subject>Helicobacter pylori</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Internship and Residency - statistics & numerical data</subject><subject>Israel</subject><subject>Lymphoma, B-Cell, Marginal Zone - diagnosis</subject><subject>Lymphoma, B-Cell, Marginal Zone - therapy</subject><subject>Medical sciences</subject><subject>Penicillins - therapeutic use</subject><subject>Peptic Ulcer - complications</subject><subject>Peptic Ulcer - diagnosis</subject><subject>Peptic Ulcer - therapy</subject><subject>Practice Guidelines as Topic</subject><subject>Referral and Consultation - statistics & numerical data</subject><subject>Stomach Neoplasms - diagnosis</subject><subject>Stomach Neoplasms - therapy</subject><subject>Tropical medicine</subject><issn>0192-0790</issn><issn>1539-2031</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU9vFCEYh4mxsWv1KxgueupYGNgBjqaxtrFJG13PhGXe2UVZWGHGzV787L7trvYkCZC8PD_-PBBCOXvPmVEXDJvUomtaxgTDgTXYOXtGZnwuDJYFf05mjJu2YcqwU_Ky1u9IKCH4C3LK27mU3KgZ-f11Kr9gT_NAxzXQu21IIad6Tj-nvIvQr4C61NP74vwYPNQHECMrQOhx5SaNUFKoY6VfYOVKH9KKXkMMPi8xA4Vu9zGXQBdQxwYTzaKAG-l9RmT_ipwMLlZ4fZzPyLerj4vL6-b27tPN5YfbxgvdsWbZ6c6DajthhIdlb0Aa08IwaMM70WmmvOFYmivBPPSDc1L0-FwtjfOt5OKMvDvsuy3554Q3sZtQPcToEuSpWtUarTjTCOoD6EuutcBgtyVsXNlbzuyDe_vXvf3n3j66x-ib4xnTcgP9U_AoG4G3R8BV7-JQXPKhPnFy3mopOuTkgdvliALrjzjtoNg1uDiu7f_-XvwBckOb_A</recordid><startdate>200302</startdate><enddate>200302</enddate><creator>Niv, Yaron</creator><creator>Abuksis, Galia</creator><general>Lippincott Williams & Wilkins, Inc</general><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>200302</creationdate><title>Survey of the Opinions, Knowledge and Practices of Surgeons and Internists Regarding Helicobacter pylori Test-and-Treat Policy</title><author>Niv, Yaron ; Abuksis, Galia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3860-b686ce726393cebd9e4992eff891636807c914995730cedfaa43d001849ac2413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Academic Medical Centers - standards</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Azithromycin - therapeutic use</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the digestive system and abdomen</topic><topic>Biological and medical sciences</topic><topic>Data Collection</topic><topic>Drug Therapy, Combination</topic><topic>Gastritis - complications</topic><topic>Gastritis - diagnosis</topic><topic>Gastritis - therapy</topic><topic>General Surgery - statistics & numerical data</topic><topic>Guideline Adherence - statistics & numerical data</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Helicobacter Infections - complications</topic><topic>Helicobacter Infections - diagnosis</topic><topic>Helicobacter Infections - therapy</topic><topic>Helicobacter pylori</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Internship and Residency - statistics & numerical data</topic><topic>Israel</topic><topic>Lymphoma, B-Cell, Marginal Zone - diagnosis</topic><topic>Lymphoma, B-Cell, Marginal Zone - therapy</topic><topic>Medical sciences</topic><topic>Penicillins - therapeutic use</topic><topic>Peptic Ulcer - complications</topic><topic>Peptic Ulcer - diagnosis</topic><topic>Peptic Ulcer - therapy</topic><topic>Practice Guidelines as Topic</topic><topic>Referral and Consultation - statistics & numerical data</topic><topic>Stomach Neoplasms - diagnosis</topic><topic>Stomach Neoplasms - therapy</topic><topic>Tropical medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niv, Yaron</creatorcontrib><creatorcontrib>Abuksis, Galia</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>Journal of clinical gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niv, Yaron</au><au>Abuksis, Galia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Survey of the Opinions, Knowledge and Practices of Surgeons and Internists Regarding Helicobacter pylori Test-and-Treat Policy</atitle><jtitle>Journal of clinical gastroenterology</jtitle><addtitle>J Clin Gastroenterol</addtitle><date>2003-02</date><risdate>2003</risdate><volume>36</volume><issue>2</issue><spage>139</spage><epage>143</epage><pages>139-143</pages><issn>0192-0790</issn><eissn>1539-2031</eissn><coden>JCGADC</coden><abstract>BACKGROUNDHelicobacter pylori infection is highly prevalent and may cause disease in 10% to 15% of infected individualsduodenal and gastric ulcer, gastric cancer and gastric lymphoma. Guidelines for a test-and-treat policy have been published by the European H. pylori working group in Maastricht.
GOALSTo assess the current approach to H. pylori–related diseases, indications for testing and eradication therapy, among internists and surgeons of a University affiliated medical center.
STUDYA 15-items questionnaire was formulated according to the Maastricht II test-and-treat recommendation and distributed among the physicians of 6 internal medicine departments and the department of surgery. The questionnaires were completed anonymously at the department's staff meeting, under the supervision of the head of the department. All questions required a yes/no answer; the maximum possible score was 15. The relative ratio (RR) of correct answers was calculated for every question and by subgroups as followsall participants, internists, surgeons, experts and residents in internal medicine and surgery.
RESULTSThe response rate was 68% (55 out of 80 physicians). Total score for all participants was 10.9 (RR = 0.73), significantly lower than the maximum score of 15 (RR = 1.00). The internists had significantly higher average score than the surgeons for 2 questionscausative agent in gastric cancer (p = 0.003) or gastric lymphoma (p = 0.003), 1 question about triple therapy, PPI, penicillin and azythromycin being not recommended (p = 0.022), and for 1 question of test-and-treat policyshould this strategy apply to family members of gastric cancer patients (p = 0.045). Only 56% of the internists and 21% of surgeons knew what MALToma is, and the correlation with H. pylori infection.
CONCLUSIONKnowledge of Surgeons and Internists regarding H. pylori infection and correlation with diseases or test and treat policy should be improved.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>12544197</pmid><doi>10.1097/00004836-200302000-00010</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0192-0790 |
| ispartof | Journal of clinical gastroenterology, 2003-02, Vol.36 (2), p.139-143 |
| issn | 0192-0790 1539-2031 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72987108 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Academic Medical Centers - standards Anti-Bacterial Agents - therapeutic use Azithromycin - therapeutic use Bacterial diseases Bacterial diseases of the digestive system and abdomen Biological and medical sciences Data Collection Drug Therapy, Combination Gastritis - complications Gastritis - diagnosis Gastritis - therapy General Surgery - statistics & numerical data Guideline Adherence - statistics & numerical data Health Knowledge, Attitudes, Practice Helicobacter Infections - complications Helicobacter Infections - diagnosis Helicobacter Infections - therapy Helicobacter pylori Human bacterial diseases Humans Infectious diseases Internship and Residency - statistics & numerical data Israel Lymphoma, B-Cell, Marginal Zone - diagnosis Lymphoma, B-Cell, Marginal Zone - therapy Medical sciences Penicillins - therapeutic use Peptic Ulcer - complications Peptic Ulcer - diagnosis Peptic Ulcer - therapy Practice Guidelines as Topic Referral and Consultation - statistics & numerical data Stomach Neoplasms - diagnosis Stomach Neoplasms - therapy Tropical medicine |
| title | Survey of the Opinions, Knowledge and Practices of Surgeons and Internists Regarding Helicobacter pylori Test-and-Treat Policy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T06%3A22%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Survey%20of%20the%20Opinions,%20Knowledge%20and%20Practices%20of%20Surgeons%20and%20Internists%20Regarding%20Helicobacter%20pylori%20Test-and-Treat%20Policy&rft.jtitle=Journal%20of%20clinical%20gastroenterology&rft.au=Niv,%20Yaron&rft.date=2003-02&rft.volume=36&rft.issue=2&rft.spage=139&rft.epage=143&rft.pages=139-143&rft.issn=0192-0790&rft.eissn=1539-2031&rft.coden=JCGADC&rft_id=info:doi/10.1097/00004836-200302000-00010&rft_dat=%3Cproquest_cross%3E72987108%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72987108&rft_id=info:pmid/12544197&rfr_iscdi=true |